Invention Grant
- Patent Title: Anti-BCMA antibodies
-
Application No.: US16026242Application Date: 2018-07-03
-
Publication No.: US11111307B2Publication Date: 2021-09-07
- Inventor: Susan L. Kalled , Yen-Ming Hsu
- Applicant: Biogen MA Inc.
- Applicant Address: US MA Cambridge
- Assignee: Biogen MA Inc.
- Current Assignee: Biogen MA Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/00
Abstract:
This invention provides antibodies that recognize the B Cell Maturation Antigen (BCMA) and that bind naïve B cells, plasma cells, and/or memory B cells. The invention further provides methods for depleting naïve B cells, plasma cells, and memory B cells, and for treating B cell-related disorders, including lymphomas and autoimmune diseases.
Public/Granted literature
- US20190161552A1 ANTI-BCMA ANTIBODIES Public/Granted day:2019-05-30
Information query
